FDA Mulls More Resources for Little-Monitored Cosmetics Industry
- Agency has discussed moving the program to the drug unit
- ‘There’s more sophistication in cosmetics,’ also ‘more risk’
This article is for subscribers only.
America’s quest for the Fountain of Youth never dries up, and the ever-more-advanced elixirs and makeup hitting shelves could use some more monitoring, Food and Drug Administration Commissioner Scott Gottlieb said.
“I’ve looked within our own budget, and we’ll probably be channeling some more of our own resources internally into the cosmetics program,” Gottlieb said in an interview Monday at Bloomberg headquarters in New York. “It’s a small program in FDA, and the industry is growing very, very large, and many more of the cosmetics have active ingredients that have drug-like qualities associated with them. So there’s more sophistication in cosmetics; there’s also potentially more risk.”